Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(23)00316-4/fulltext?dgcid=hubspot_email_conferencealerts_sccm24&utm_campaign=conferencealerts&utm_medium=email&_hsmi=290937100&_hsenc=p2ANqtz--8BcuY-1Fb6cZy2cjTkF6C5mZus47kY-67MVuuLEfILFX2yCC9n5xpaZ3H4VZDAKi4B8dpCkMrEYlodFd0kl2fRSO_pw&utm_content=290937100&utm_source=hs_email